AI-assisted SEP Prosecution to Build Portfolios for Licensing, Sale, or Enforcement

Standard-essential patents (SEPs) are among the most valuable assets in today’s technology economy. They form the foundation of licensing programs, determine competitive positioning, and increasingly become the center of high-stakes litigation across multiple jurisdictions. Yet one reality remains unchanged: many SEPs that initially appear to be strong eventually fail when scrutinized in court.

Federal Circuit Affirms Indefiniteness of Breathable Membrane Patent Claims Over Unspecified Measurement Method

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Tuesday in Cocona, Inc. v. VF Outdoor, LLC, affirming a judgment of the U.S. District Court for the District of Colorado that held three claims of a waterproof, breathable membrane patent invalid as indefinite. Circuit Judge Stark wrote for the court, joined by Circuit Judges Lourie and Stoll, and agreed with the district court that the asserted claims recited a numerical range for moisture vapor transmission rate (MVTR) without specifying a method for measuring it.

Patents Pitted Against PBMs in Senate Judiciary Hearing on U.S. Drug Prices

The full Senate Judiciary Committee today heard from five witnesses who urged senators to take action to curb pharmaceutical industry and pharmacy benefit manager (PBM) practices, which they alternately blamed for high U.S. drug costs. While some senators warned that targeting drug makers could have unintended consequences, most supported moving quickly on legislation they claim would lower prices for U.S. consumers, a claim industry has called a “myth”.

Solutions Still in Search of a Problem: Seeing Through False Narratives on Patents on Medicines

Critics of the pharmaceutical patent system often claim that manufacturers use large patent portfolios to delay competition. A new paper in the Journal of Law and the Biosciences offers the latest version of that argument, focusing specifically on biologics. The authors compare biologic patent portfolios in the United States, Europe, and Japan. They find that the largest patent portfolios are in the United States—and that biologics are associated with more patents than traditional small-molecule drugs. This may be true, but it does not demonstrate that a problem exists. 

CAFC Orders Dismissal of Patent Owner’s Independent Action Seeking to Void Verizon Fee Award

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision on Monday in Traxcell Technologies, LLC v. Cellco Partnership, dba Verizon Wireless, vacating a judgment of the U.S. District Court for the Western District of Texas and remanding with instructions to dismiss Traxcell’s independent action for lack of jurisdiction. Traxcell brought the action seeking to void an attorneys’ fee award that the U.S. District Court for the Eastern District of Texas granted to Verizon under 35 U.S.C. Section 285, an award the CAFC had previously affirmed.

Gilead Wins $69 Million Damages, Permanent Injunction Against Defaulting Defendants in HIV Counterfeiting Ring

Last Friday, U.S. District Judge Natasha Merle of the Eastern District of New York entered an order adopting a U.S. magistrate judge’s report and recommendation to grant Gilead Sciences’ motion for default judgment against eight individuals and 18 shell companies involved in a conspiracy to market counterfeit HIV treatments, many of them improperly labelled and sold with falsified chain-of-sale documents.

China’s Automotive Surge in Brazil Is Reshaping the Patent Landscape

Imports of Chinese electric and hybrid vehicles are transforming Brazil’s automotive market. At the same time, data from the Brazilian Patent and Trademark Office (BPTO) show Chinese companies expanding their patent presence. Together, these trends suggest a new phase of competition in which electrification, software and artificial intelligence (AI) may matter as much as manufacturing scale and dealer networks.

Subscribe to IPWatchdog

This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.

Get Email Updates